Natural Remedies’ Ashwa.30 clinches prestigious Innovation Award at Vitafoods Europe 2026

As one of many nutraceutical trade’s most prestigious international platforms, Vitafoods Europe recognises excellence in scientific development and market-leading options. This win marks a big milestone for Ashwa.30, coming shortly after its latest success on the Vitafoods India 2026 Innovation Awards, additional cementing its place as a world chief within the ashwagandha market.

The Science Behind the Success

Ashwa.30 is a 100% root-derived Ashwagandha extract, uniquely standardised to a 30% Ashwa Bio-Active Complex. This profile contains:

• 15% Withanolides: Supports stress and cortisol steadiness.
• 15% ATP Actives: Specifically focused for vitality, endurance mobile vitality and longevity.

Developed utilizing cutting-edge BOT (Bio-Optimized Technology), Ashwa.30 gives an answer requiring solely a 30mg day by day dose.

Redefining the Active Lifestyle Category

The award acknowledges Ashwa.30’s capability to satisfy the rigorous calls for of recent shoppers. Backed by seven medical validations, the ingredient is scientifically confirmed to handle the core pillars of an energetic way of life:

“This recognition reflects the growing global relevance of clinically validated botanical solutions,” mentioned a spokesperson for Natural Remedies. “Our achievement at Vitafoods Europe reinforces Ashwa.30’s scientific credibility, its differentiated positioning in a crowded market, and its profound impact across global regions.”

Setting a New Standard

While conventional ashwagandha extracts usually require a lot greater dosages, Ashwa.30’s low-dose efficacy makes it a flexible alternative for producers seeking to innovate within the dietary supplements, practical meals, and beverage sectors. This second consecutive award in 2026 underscores Natural Remedies’ dedication to bridging the hole between historical botanical knowledge and fashionable medical science.